PURPOSE Since the introduction ofGa-PSMA-11 PET/CT for imaging prostate cancer (PC) we have frequently observed mediastinal lymph nodes (LN) showing tracer uptake despite being classified as benign. The aim of this evaluation was to further analyze such LN. METHODS Two patient groups with biphasicGa-PSMA-11 PET/CT at 1 h and 3 h p.i. were included in this retrospective evaluation. Group A (n = 38) included patients without LN metastases, and group B (n = 43) patients with LN metastases of PC. SUV of mediastinal/paraaortal LN of group A (n = 100) were compared to SUV of LN metastases of group B (n = 91). Additionally, 22 randomly selected mediastinal and paraaortal LN of patients without PC were immunohistochemically (IHC) analyzed ...
Radiolabelled prostate-specific membrane antigen (PSMA)-based PET–CT has been shown in numerous stud...
68Ga-prostate-specific membrane antigen (PSMA) PET/CT is a new method to detect early nodal metastas...
PURPOSE: Since the introduction of PSMA PET/CT with 68Ga-PSMA-11, this modality for imaging prosta...
PURPOSE: Since the introduction of 68Ga-PSMA-11 PET/CT for imaging prostate cancer (PC) we have ...
PURPOSE: Intraoperative identification of lymph node (LN) metastases (LNM) detected on preoperativ...
CITATION: Jilg, C. A., et al. 2020. Results from extended lymphadenectomies with [111In]PSMA-617 for...
Background: To determine the potential role of Ga-68-PSMA positron emission tomography/computed tomo...
PURPOSE Dual-time point PET/CT scanning with [68Ga]Ga-PSMA-11 in the diagnosis of prostate cancer...
PURPOSE PSMA-targeted PET in patients with prostate cancer (PCa) has a significant impact on trea...
PURPOSE Differentiating between prostate cancer (PC) lesions and benign structures which exhibit ...
PurposeTo determine the clinical value of two novel molecular imaging techniques: 11C-choline positr...
Recent randomised evidence supports the diagnostic superiority of prostate-specific membrane antigen...
Purpose: Prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) imagi...
Aim: To assess whether clinical prostate cancer (PCA) related factors and therapy status can predict...
Purpose: The early and accurate diagnosis of locoregional recurrence or metastasis in prostate cance...
Radiolabelled prostate-specific membrane antigen (PSMA)-based PET–CT has been shown in numerous stud...
68Ga-prostate-specific membrane antigen (PSMA) PET/CT is a new method to detect early nodal metastas...
PURPOSE: Since the introduction of PSMA PET/CT with 68Ga-PSMA-11, this modality for imaging prosta...
PURPOSE: Since the introduction of 68Ga-PSMA-11 PET/CT for imaging prostate cancer (PC) we have ...
PURPOSE: Intraoperative identification of lymph node (LN) metastases (LNM) detected on preoperativ...
CITATION: Jilg, C. A., et al. 2020. Results from extended lymphadenectomies with [111In]PSMA-617 for...
Background: To determine the potential role of Ga-68-PSMA positron emission tomography/computed tomo...
PURPOSE Dual-time point PET/CT scanning with [68Ga]Ga-PSMA-11 in the diagnosis of prostate cancer...
PURPOSE PSMA-targeted PET in patients with prostate cancer (PCa) has a significant impact on trea...
PURPOSE Differentiating between prostate cancer (PC) lesions and benign structures which exhibit ...
PurposeTo determine the clinical value of two novel molecular imaging techniques: 11C-choline positr...
Recent randomised evidence supports the diagnostic superiority of prostate-specific membrane antigen...
Purpose: Prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) imagi...
Aim: To assess whether clinical prostate cancer (PCA) related factors and therapy status can predict...
Purpose: The early and accurate diagnosis of locoregional recurrence or metastasis in prostate cance...
Radiolabelled prostate-specific membrane antigen (PSMA)-based PET–CT has been shown in numerous stud...
68Ga-prostate-specific membrane antigen (PSMA) PET/CT is a new method to detect early nodal metastas...
PURPOSE: Since the introduction of PSMA PET/CT with 68Ga-PSMA-11, this modality for imaging prosta...